SNSE- Sensei Biotherapeutics, Inc.

Insider activity in SNSE over the last quarter tilts toward selling: insiders offloaded a net 34,359 shares worth roughly $600K.

Classified under Biotechnology (Health Care sector), SNSE's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
COO	Parikh Anand Kiran	1.24M	-	-
Pres	Gerry Christopher	220.0K	-	-
10%	Peyer James	130.6K	$2.61M	-
10%	Cambrian Biopharma Inc	130.6K	$2.61M	-
Other	Craver Josiah	80.0K	-	-

Buys and sells only

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 10, 2022	Cambrian Biopharma Inc	10% Owner	Buy	10,000	$5.28	$52,800.00	+0.2%	-60.8%	-71.0%
Jan 10, 2022	Peyer James	Director, 10% Owner	Buy	10,000	$5.28	$52,800.00	+0.2%	-60.8%	-71.0%
Dec 30, 2021	Cambrian Biopharma Inc	10% Owner	Buy	1,127	$4.85	$5,465.95	-	-58.2%	-73.2%
Dec 30, 2021	Peyer James	Director, 10% Owner	Buy	1,127	$4.85	$5,465.95	-	-58.2%	-73.2%
Dec 29, 2021	Cambrian Biopharma Inc	10% Owner	Buy	69,000	$4.98	$343,620.00	+1.4%	-54.2%	-70.3%
Dec 29, 2021	Peyer James	Director, 10% Owner	Buy	69,000	$4.98	$343,620.00	+1.4%	-54.2%	-70.3%
Dec 28, 2021	Peyer James	Director, 10% Owner	Buy	11,288	$5.28	$59,600.64	+0.2%	-57.8%	-73.7%
Dec 28, 2021	Cambrian Biopharma Inc	10% Owner	Buy	11,288	$5.28	$59,600.64	+0.2%	-57.8%	-73.7%
Dec 27, 2021	Peyer James	Director, 10% Owner	Buy	3,712	$5.30	$19,673.60	-	-58.4%	-74.6%
Dec 27, 2021	Cambrian Biopharma Inc	10% Owner	Buy	3,712	$5.30	$19,673.60	-	-58.4%	-74.6%